Research published in late 2024 in the journal JAMA Pediatrics found nirsevimab was more than 90 percent effective at preventing hospitalization for RSV, and 89 percent effective at preventing all ...

The University of Pittsburgh Medical Center - which treats millions of patients - has announced it will begin requiring face ...

The respiratory tract’s microbial microflora plays a significant role in determining the severity of RSV infections and the ...

Adult, 4 juveniles arrested after 2 carjackings in north Indianapolis ...

What are the symptoms of RSV and who is eligible for a vaccine? - RSV might at first seem like a cold but it can quickly ...

Those most at risk from RSV include babies under 6 months old, young children who were born prematurely, and adults over ...

With data showing a significant rise in flu cases nationwide, medical experts are describing it as the worst flu season since ...

With respiratory illness season at its peak, the latest CDC data shows a significant rise in flu cases nationwide, while ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

According to January 31, 2025 data posted by the Maricopa County Department of Public Health’s Respiratory Virus Surveillance ...

“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...